Upgrade to SI Premium - Free Trial

Hologic (HOLX) PT Lowered to $84 at Raymond James

February 3, 2022 5:41 AM
Raymond James analyst Jayson Bedford lowered the price target on Hologic (NASDAQ: HOLX) to $84.00 (from $88.00) while maintaining a Outperform rating.

Categories

Analyst PT Change

Next Articles